[go: up one dir, main page]

BR0016469A - Composition to improve the proliferative response during adaptation of the gastrointestinal tract and use in small intestine syndrome - Google Patents

Composition to improve the proliferative response during adaptation of the gastrointestinal tract and use in small intestine syndrome

Info

Publication number
BR0016469A
BR0016469A BR0016469-0A BR0016469A BR0016469A BR 0016469 A BR0016469 A BR 0016469A BR 0016469 A BR0016469 A BR 0016469A BR 0016469 A BR0016469 A BR 0016469A
Authority
BR
Brazil
Prior art keywords
composition
improve
gastrointestinal tract
proliferative response
response during
Prior art date
Application number
BR0016469-0A
Other languages
Portuguese (pt)
Inventor
Jon Arvud Vanderhoof
Kathryn Anne Kollman
Eric Louis Lien
John Charles Wallingford
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0016469A publication Critical patent/BR0016469A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO PARA MELHORAR A RESPOSTA PROLIFERATIVA DURANTE A ADAPTAçãO DO TRATO GASTROINTESTINAL E USO NA SìNDROME DO INTESTINO DELGADO". São fornecidos processos para o tratamento da síndrome do intestino delgado em pacientes que necessitam o mesmo, que compreende administrar nos pacientes uma quantidade eficaz de uma formulação que compreende ácido araquidónico e ácido docosahexanóico."COMPOSITION TO IMPROVE THE PROLIFERATIVE RESPONSE DURING ADAPTATION OF THE GASTROINTESTINAL TRACT AND USE IN THE SMALL GUT SYNDROME". Processes are provided for the treatment of small bowel syndrome in patients who need it, which comprises administering to patients an effective amount of a formulation comprising arachidonic acid and docosahexanoic acid.

BR0016469-0A 1999-12-17 2000-12-14 Composition to improve the proliferative response during adaptation of the gastrointestinal tract and use in small intestine syndrome BR0016469A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46675199A 1999-12-17 1999-12-17
PCT/US2000/033783 WO2001043570A1 (en) 1999-12-17 2000-12-14 Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome

Publications (1)

Publication Number Publication Date
BR0016469A true BR0016469A (en) 2002-08-27

Family

ID=23852961

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016469-0A BR0016469A (en) 1999-12-17 2000-12-14 Composition to improve the proliferative response during adaptation of the gastrointestinal tract and use in small intestine syndrome

Country Status (18)

Country Link
EP (1) EP1237424A1 (en)
JP (1) JP2003516946A (en)
KR (1) KR20030016211A (en)
CN (1) CN1411347A (en)
AR (1) AR026988A1 (en)
AU (1) AU2095101A (en)
BR (1) BR0016469A (en)
CA (1) CA2391259A1 (en)
CZ (1) CZ20021960A3 (en)
EA (1) EA200200687A1 (en)
HU (1) HUP0203654A3 (en)
IL (1) IL149805A0 (en)
MX (1) MXPA02005940A (en)
NO (1) NO20022865D0 (en)
NZ (1) NZ519932A (en)
PL (1) PL356781A1 (en)
WO (1) WO2001043570A1 (en)
ZA (1) ZA200205673B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4694053B2 (en) * 2001-07-03 2011-06-01 森永乳業株式会社 Infant nutrition composition
CN101437410A (en) * 2006-03-23 2009-05-20 雀巢产品技术援助有限公司 High calorie nutritional supplement
WO2012092086A1 (en) * 2010-12-29 2012-07-05 Abbott Laboratories Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
CN115886288A (en) * 2022-12-05 2023-04-04 四川大学 A polyphenol-based modified nutritional substance material for the treatment of short bowel syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2033193B1 (en) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro FAT MIXTURE FOR CHILD AND ADULT NUTRITION.
US6200624B1 (en) * 1996-01-26 2001-03-13 Abbott Laboratories Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
JP3720375B2 (en) * 1996-03-26 2005-11-24 ギスト ブロカデス ベスローテン フェンノートシャップ Polyunsaturated fatty acid coated solid carrier particles for food
JP3627043B2 (en) * 1996-04-24 2005-03-09 明治乳業株式会社 n-6 series / n-3 series fatty acid balance improved nucleotide-containing baby food

Also Published As

Publication number Publication date
HUP0203654A2 (en) 2003-04-28
EP1237424A1 (en) 2002-09-11
ZA200205673B (en) 2004-02-23
AR026988A1 (en) 2003-03-05
KR20030016211A (en) 2003-02-26
WO2001043570A1 (en) 2001-06-21
PL356781A1 (en) 2004-07-12
NO20022865L (en) 2002-06-14
NZ519932A (en) 2004-02-27
JP2003516946A (en) 2003-05-20
HUP0203654A3 (en) 2003-10-28
IL149805A0 (en) 2002-11-10
AU2095101A (en) 2001-06-25
CZ20021960A3 (en) 2003-03-12
NO20022865D0 (en) 2002-06-14
EA200200687A1 (en) 2003-02-27
CN1411347A (en) 2003-04-16
CA2391259A1 (en) 2001-06-21
MXPA02005940A (en) 2003-10-14

Similar Documents

Publication Publication Date Title
EE05404B1 (en) A quinuclidine derivative, its preparation and its use in the preparation of a medicament for the treatment of respiratory, urinary or gastrointestinal diseases, and a pharmaceutical composition containing it
CY1105707T1 (en) COMBINATIONS OF FORMOTEROL AND A TRIOTROP SALT
BR0008276A (en) Combinations of formoterol and fluticasone propionate for asthma
EE200300295A (en) A quinuclidine carbamate derivative, its preparation and its use in the preparation of a medicament for the treatment of respiratory, urinary or gastrointestinal diseases, and a pharmaceutical composition containing it.
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
ID30171A (en) FORMOTEROL COMBINATIONS AND FUROAT MOMETASONS FOR ASMA
BR0116370A (en) Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient.
PT1083879E (en) METHODS AND DEVICES TO PROVIDE A PROLONGED DRUG THERAPY
ATE380023T1 (en) ORAL SOLID PHARMACEUTICAL COMPOSITIONS FOR PH-DEPENDENT MULTIPHASE RELEASE
DK1326644T3 (en) Absorption promoters
BR0008403A (en) Pharmaceutical formulation for oral administration
NZ544645A (en) Use of calcitonin in osteoarthritis
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
WO2003000242A3 (en) Method for the treatment of lymphedema using guaifenesin
DE50005529D1 (en) ORAL PHARMACEUTICAL FORMS FOR ADMINISTRATING A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
TR200002969T2 (en) Pharmaceutical composition.
NO20034863D0 (en) Deuterated 3-piperidinopropiophenone and drugs containing them
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
NO20016004D0 (en) Composition comprising alkaline sphingomyelinase for use as a dietary, nutritional supplement or pharmaceutical product
HUP0203303A3 (en) Compositions for administering taxanes orally to human patients
BR0016469A (en) Composition to improve the proliferative response during adaptation of the gastrointestinal tract and use in small intestine syndrome
UA90893C2 (en) Oral dosage forms of gemcitabine derivatives
NO20024673D0 (en) Controlled-release pharmaceutical composition for oral use containing midodrine and / or desglymidodrine
BR9714179A (en) Absorbable composition containing propionic bacteria capable of releasing nitrogen monoxide in the human or animal digestive tract
EP1099439A3 (en) Use of apo B secretion/MTP inhibitors

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. A CLASSIFICACAO IPC ANTERIOR ERA A23L 1/30.

Ipc: A23L 33/12 (2016.01), A23L 33/00 (2016.01)

Ipc: A23L 33/12 (2016.01), A23L 33/00 (2016.01)